Showing 9 of 9 recruiting trials for “Squamous cell carcinoma of the hypopharynx”
A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
👨⚕️ Winston Wong, MD, Memorial Sloan Kettering Cancer Center📍 7 sites📅 Started Jul 2025View details ↗
Thermoradiotherapy for Locally Advanced Head and Neck Cancer Patients
Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma
RecruitingNCT06380686 ↗
Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome
👨⚕️ Victor Grünwald, Prof. Dr., Universitätsklinikum Essen📍 2 sites📅 Started Nov 2024View details ↗
A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)
Personalized Elective Neck Irradiation Guided by Sentinel Lymph Node Biopsy in Larynx and Pharynx Cancer. The PRIMO Study.
First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →